[Federal Register Volume 63, Number 186 (Friday, September 25, 1998)]
[Rules and Regulations]
[Page 51299]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X98-10925]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 5


Delegations of authority and Organization

CFR Correction

    In Title 21 of the Code of Federal Regulations, parts 1 to 99, 
revised as of Apr. 1, 1998, page 42, Sec. 5.33(c) was inadvertently 
removed and is reinstated to read as follows:


5.33  Premarket approval of a product that is or contains a biologic, a 
device, or a drug.

* * * * *
    (c) The Director, Deputy Center Director for Review Management, and 
Deputy Center Director for Pharmaceutical Science, Center for Drug 
Evaluation and Research (CDER); and the Directors of the Offices of 
Drug Evaluation I, II, III, IV, and V, Office of Review Management, 
CDER.

BILLING CODE 1505-01-D